Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
Clinical trial NCT01986920 · COMPLETED
Trial details
- NCT number
- NCT01986920
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-22
- Primary completion
- 2014-02-25
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.